Open Payments

Hunterdon Medical Center

Type
Teaching hospital
Where
Flemington, NJ
Medicare CCN
310005
Received
$649,730 in 30 records, 2024 ($46,653 general, $603,077 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2024General payment9$46,653
2024Research payment21$603,077

By company

CompanyRecordsAmountYears
PFIZER INC.21$603,0772024
Olympus America Inc.2$30,7362024
Stryker Corporation5$15,6322024
Siemens Medical Solutions USA, Inc.1$1992024
Baxter Healthcare1$852024

By nature of payment

NatureRecordsAmount
Research payment21$603,077
Debt forgiveness5$31,076
Long term medical supply or device loan4$15,577

Records

DateCompanyAmountNatureFormProductStudyYear
2024-12-31Stryker Corporation$4,097Long term medical supply or device loanIn-kind items and servicesConnected OR Hub Device, ENDOSCOPY2024
2024-12-31Stryker Corporation$4,097Long term medical supply or device loanIn-kind items and servicesConnected OR Hub Device, ENDOSCOPY2024
2024-12-31Stryker Corporation$4,045Long term medical supply or device loanIn-kind items and servicesNA Device, INSTRUMENTS2024
2024-12-31Stryker Corporation$3,336Long term medical supply or device loanIn-kind items and servicesCrossfire Device, ENDOSCOPY2024
2024-12-31Siemens Medical Solutions USA, Inc.$199Debt forgivenessIn-kind items and services2024
2024-12-31Stryker Corporation$55Debt forgivenessCash or cash equivalent2024
2024-12-28PFIZER INC.$21,039Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-12-18PFIZER INC.$58,957Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-11-23PFIZER INC.$49,456Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-10-23Baxter Healthcare$85Debt forgivenessIn-kind items and servicesHillrom - MetaNeb System Device, Airway Clearance Device2024
2024-10-22PFIZER INC.$1,738Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-09-28PFIZER INC.$75Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-09-27PFIZER INC.$18,985Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-08-22PFIZER INC.$49,754Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-07-30Olympus America Inc.$922Debt forgivenessIn-kind items and servicesEVIS EXERA III COLONOVIDEOSCOPE Device, Gastroenterology2024
2024-07-23PFIZER INC.$8,347Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-06-25PFIZER INC.$27,959Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-06-07PFIZER INC.$31,732Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-05-30Olympus America Inc.$29,814Debt forgivenessIn-kind items and servicesBovie Device, Urology Gynecology2024
2024-05-18PFIZER INC.$49,140Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-05-01PFIZER INC.$43,098Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-04-16PFIZER INC.$35,752Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-04-09PFIZER INC.$40,887Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-04-02PFIZER INC.$33,423Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-03-28PFIZER INC.$77,228Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-03-27PFIZER INC.$27,990Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-03-02PFIZER INC.$11,797Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-03-01PFIZER INC.$3,828Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-01-24PFIZER INC.$4,785Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024
2024-01-06PFIZER INC.$7,099Research paymentCash or cash equivalentA PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM2024

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Hunterdon CountyFlemington borough

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Flemington, NJ, county Hunterdon County, NJ, state New Jersey; placed by its city name.

MeasurePlace (city or town)
Flemington, NJ
County
Hunterdon County, NJ
State
New Jersey
Population B010034,896130,1609,343,809
Population, 2020 census P14,876128,9479,288,994
Median age B0100234.246.140.1
Under 18 B0100119.6%19.1%21.8%
65 and over B0100113.7%20.8%17.2%
Households B110012,11950,8603,507,701
Foreign born B0500231.1%10.6%23.9%
Median household income B19013$69,978$141,715$103,556
Median family income B19113$112,604$171,597$127,025
Per capita income B19301$45,921$72,227$54,253
Poverty rate B1700111.8%4.0%9.7%
Unemployment rate B230251.2%4.6%6.3%
Civilian labor force B230252,78170,5265,003,179
Mean commute (minutes) B0801322.733.030.5
Bachelor's degree or higher B1500339.8%57.4%43.6%
Housing units B250012,19152,1153,791,354
Owner-occupied B2500334.1%85.1%63.8%
Renters B2500365.9%14.9%36.2%
Median home value B25077$400,600$517,200$454,400
Median gross rent B25064$1,532$1,687$1,720
White, not Hispanic B0300256.1%79.9%50.9%
Black B030022.7%2.4%12.2%
Hispanic or Latino B0300234.1%9.3%22.5%
Asian B030026.3%4.9%10.0%
American Indian and Alaska Native B030020.0%0.0%0.1%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Flemington, NJ.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.